Table 3.

Basal and postprandial glucose, insulin and C-peptide levels on the 1st and 12th days from the Ml

Variables	Control (n = 30)		Patients with Ml (n = 65)			Patients with Ml and type 2 diabetes mellitus (n = 60)
	Basal level	Postprandial level	1st day	12th day		1st day	12th day
				Basal level	Postprandial level		Basal level	Postprandial level
Glucose, mmol/L	5.19 (3.8; 5.5)	4.40 (3.87; 5.1)	6.2 (5.50; 6.35)*,#	6.30 (5.50; 6.40)#	6.00 (4.90; 6.80)*,#	9.88 (7.60; 12.50)*	9.99(7.20; 11.35)	11.23 (7.85; 11.95)*,&
Insulin, mU/mL	12.5(8.7; 18.5)	21.1 (7.86; 23.4)	14.93 (6.48; 19.70)	15.76 (8.60; 20.70)	35.90 (3.45; 51.31)*,&	14.77 (7.43; 22.55)	15.20 (8.75; 21.71)	37.21 (3.97;46.12)*,&
C-peptide, ng/mL	1.2(0.73; 1.87)	1.78 (0.75; 2.1)	1.48 (0.77; 2.03)	1.23 (0.77; 1.96)	2.59 (1.34; 3.97)*,&,#	1.32(0.92; 1.75)	1.67 (0.86; 2.29)	4.23 (1.82; 6.48)*,&

Notes: The results are presented as median and quartiles (Me [Q₁;Q₃]).

^*Reliable differences from controls (P < 0.05);

^#reliable differences among patients with both Ml and type 2 diabetes and among patients without type 2 diabetes mellitus (P < 0.05);

^&reliable differences in basal and in postprandial glucose, insulin, and C-peptide level (P < 0.05).

Abbreviation: Ml, myocardial infarction.